investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition
Scott Kopetz
5 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hagen Kennecke
Vancouver Hospital and Health Sciences Centre
Vancouver, Canada
BC Cancer Agency
Vancouver, Canada
Stanley Hamilton
University of Texas MD Anderson Cancer Center
Houston, United States
Jeffrey Morris
University of Texas MD Anderson Cancer Center
Houston, United States
Edmund Kopetz
University of Texas MD Anderson Cancer Center
Houston, United States
Brian James
Sanford-Burnham Medical Research Institute
La Jolla, United States
Scott Kopetz
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Scott Durum
Chronic Inflammation and Carcinogenesis
Colorectum
David S. Hong
Therapeutic Strategies for Patients With BRAF Mutant Colorectal Cancer
Colorectum
Thomas Hudson
High resolution genetic analysis of genetic loci implicated in colorectal cancer
Colorectum
Barbara H Jung
Activin Signaling and Regulation in the Colon
Colorectum
Nathalie Rivard
Colorectal Cancer Research (CANADA RESEARCH CHAIRHOLDER)
Colorectum
Shahinaz Gadalla
Myotonic Dystrophy Tumorigenesis: Risk Factors and Molecular Mechanisms
Colorectum
Sparreboom Alexander
Solute Carriers and Oxaliplatin Neurotoxicity
Colorectum
Pathology
Scott Kopetz
AMPK Directs the Balance Between Mutant Kras and PI3K Signaling and Defines Molecular Subsets in Colorectal Cancer
Colorectum
Thomas Ried
Prediction of Therapy Response in Colorectal Cancer
Colorectum
Radiation Oncology
